Fusion Pharmaceuticals
Fusion Pharma develops and commercializes targeted alpha-particle radiotherapeutics for the treatment of cancer.
Business Model:
Revenue: $1.6M
Employees: 51-200
Industries / Tags:
Detailed Fusion Pharmaceuticals Information
Geographic Data
Address: 270 Longwood Road South
City: Hamilton
State: ontario
Zip: L8P 0A6
Country: CA
Financial Info
Stage:
series unknown
Raised Last:
$20M
Raised Total:$171M
Social
Metrics
6,109,309Website Global Rank
1,216Website Monthly Traffic
Twitter Followers
Description
Fusion Pharma develops and commercializes targeted alpha-particle radiotherapeutics for the treatment of cancer.
Contact Phone:
Contact Email:
Fusion Pharmaceuticals went public on 6/25/2020 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
6/25/2020
IPO Valuation:
$708M
Ticker Symbol:
FUSN
IPO Price:
$17/share
Amount Raised:
$213M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
